• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结直肠癌共生细菌组的改变及其在手术后的持续性:一项初步研究。

Alterations in co-abundant bacteriome in colorectal cancer and its persistence after surgery: a pilot study.

机构信息

Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.

Division of Colorectal Surgery, Department of Surgery, National University Hospital, Singapore, Singapore.

出版信息

Sci Rep. 2022 Jun 14;12(1):9829. doi: 10.1038/s41598-022-14203-z.

DOI:10.1038/s41598-022-14203-z
PMID:35701595
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9198081/
Abstract

There is growing interest in the role of gut microbiome in colorectal cancer (CRC), ranging from screening to disease recurrence. Our study aims to identify microbial markers characteristic of CRC and to examine if changes in bacteriome persist after surgery. Forty-nine fecal samples from 25 non-cancer (NC) individuals and 12 CRC patients, before and 6-months after surgery, were collected for analysis by bacterial 16S rRNA gene sequencing. Bacterial richness and diversity were reduced, while pro-carcinogenic bacteria such as Bacteroides fragilis and Odoribacter splanchnicus were increased in CRC patients compared to NC group. These differences were no longer observed after surgery. Comparison between pre-op and post-op CRC showed increased abundance of probiotic bacteria after surgery. Concomitantly, bacteria associated with CRC progression were observed to have increased after surgery, implying persistent dysbiosis. In addition, functional pathway predictions based on the bacterial 16S rRNA gene data showed that various pathways were differentially enriched in CRC compared to NC. Microbiome signatures characteristic of CRC comprise altered bacterial composition. Elements of these dysbiotic signatures persists even after surgery, suggesting possible field-change in remnant non-diseased colon. Future studies should involve a larger sample size with microbiome data collected at multiple time points after surgery to examine if these dysbiotic patterns truly persist and also correlate with disease outcomes.

摘要

人们对肠道微生物组在结直肠癌(CRC)中的作用越来越感兴趣,从筛查到疾病复发。我们的研究旨在确定CRC 特征性的微生物标志物,并检查在手术后细菌组是否会发生变化。收集了 25 名非癌症(NC)个体和 12 名 CRC 患者的 49 份粪便样本,在手术前和手术后 6 个月进行细菌 16S rRNA 基因测序分析。与 NC 组相比,CRC 患者的细菌丰富度和多样性降低,而促癌细菌如梭状芽孢杆菌和内脏杆菌的丰度增加。这些差异在手术后不再观察到。在 CRC 患者的术前和术后比较中,术后益生菌细菌的丰度增加。同时,观察到与 CRC 进展相关的细菌在手术后增加,这意味着持续的肠道菌群失调。此外,基于细菌 16S rRNA 基因数据的功能途径预测表明,与 NC 相比,CRC 中存在各种途径的差异富集。CRC 特征性的微生物组特征包括细菌组成的改变。即使在手术后,这些肠道菌群失调特征的某些元素仍然存在,这表明残余非病变结肠可能存在潜在的变化。未来的研究应该包括更大的样本量,并在手术后多个时间点收集微生物组数据,以检查这些肠道菌群失调模式是否确实持续存在,并与疾病结果相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bfd/9198081/f2bfcae58e44/41598_2022_14203_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bfd/9198081/cd7e7dbb7c5a/41598_2022_14203_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bfd/9198081/482d1305e7d3/41598_2022_14203_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bfd/9198081/9fd429dba2eb/41598_2022_14203_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bfd/9198081/e1a2f472528d/41598_2022_14203_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bfd/9198081/f2bfcae58e44/41598_2022_14203_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bfd/9198081/cd7e7dbb7c5a/41598_2022_14203_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bfd/9198081/482d1305e7d3/41598_2022_14203_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bfd/9198081/9fd429dba2eb/41598_2022_14203_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bfd/9198081/e1a2f472528d/41598_2022_14203_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bfd/9198081/f2bfcae58e44/41598_2022_14203_Fig5_HTML.jpg

相似文献

1
Alterations in co-abundant bacteriome in colorectal cancer and its persistence after surgery: a pilot study.结直肠癌共生细菌组的改变及其在手术后的持续性:一项初步研究。
Sci Rep. 2022 Jun 14;12(1):9829. doi: 10.1038/s41598-022-14203-z.
2
Alterations in colorectal cancer virome and its persistence after surgery.结直肠癌病毒组的改变及其在手术后的持续存在。
Sci Rep. 2024 Feb 3;14(1):2819. doi: 10.1038/s41598-024-53041-z.
3
Tissue-Associated Bacterial Alterations in Rectal Carcinoma Patients Revealed by 16S rRNA Community Profiling.通过16S rRNA群落分析揭示的直肠癌患者组织相关细菌改变
Front Cell Infect Microbiol. 2016 Dec 9;6:179. doi: 10.3389/fcimb.2016.00179. eCollection 2016.
4
Gut microbiota dysbiosis signature is associated with the colorectal carcinogenesis sequence and improves the diagnosis of colorectal lesions.肠道微生物失调特征与结直肠癌变序列相关,并能提高结直肠病变的诊断效能。
J Gastroenterol Hepatol. 2020 Dec;35(12):2109-2121. doi: 10.1111/jgh.15077. Epub 2020 Jun 22.
5
Potential of fecal microbiota for detection and postoperative surveillance of colorectal cancer.粪便微生物群在结直肠癌的检测和术后监测中的潜力。
BMC Microbiol. 2021 May 27;21(1):156. doi: 10.1186/s12866-021-02182-6.
6
16S rRNA of Mucosal Colon Microbiome and CCL2 Circulating Levels Are Potential Biomarkers in Colorectal Cancer.黏膜结肠微生物组 16S rRNA 和 CCL2 循环水平可能是结直肠癌的生物标志物。
Int J Mol Sci. 2021 Oct 4;22(19):10747. doi: 10.3390/ijms221910747.
7
Alterations of the Gut Microbiome and Fecal Metabolome in Colorectal Cancer: Implication of Intestinal Metabolism for Tumorigenesis.结直肠癌中肠道微生物群和粪便代谢组的改变:肠道代谢对肿瘤发生的影响
Front Physiol. 2022 May 4;13:854545. doi: 10.3389/fphys.2022.854545. eCollection 2022.
8
Altered intestinal microbiota associated with colorectal cancer.与结直肠癌相关的肠道微生物菌群改变。
Front Med. 2019 Aug;13(4):461-470. doi: 10.1007/s11684-019-0695-7. Epub 2019 Jun 28.
9
Human oral microbiome dysbiosis as a novel non-invasive biomarker in detection of colorectal cancer.人类口腔微生物组失调作为一种新型非侵入性生物标志物在结直肠癌检测中的应用。
Theranostics. 2020 Sep 18;10(25):11595-11606. doi: 10.7150/thno.49515. eCollection 2020.
10
Metagenome Analysis of Intestinal Bacteria in Healthy People, Patients With Inflammatory Bowel Disease and Colorectal Cancer.健康人群、炎症性肠病和结直肠癌患者肠道细菌的宏基因组分析。
Front Cell Infect Microbiol. 2021 Feb 26;11:599734. doi: 10.3389/fcimb.2021.599734. eCollection 2021.

引用本文的文献

1
A comprehensive multi-omics analysis uncovers the associations between gut microbiota and pancreatic cancer.一项全面的多组学分析揭示了肠道微生物群与胰腺癌之间的关联。
Front Microbiol. 2025 May 1;16:1592549. doi: 10.3389/fmicb.2025.1592549. eCollection 2025.
2
Odoribacter splanchnicus-A Next-Generation Probiotic Candidate.内脏气味杆菌——下一代益生菌候选菌株
Microorganisms. 2025 Apr 3;13(4):815. doi: 10.3390/microorganisms13040815.
3
The effect of tumor resection on intestinal microbiota dysbiosis in patients with right-sided colon cancer.

本文引用的文献

1
Cell-Free Supernatant of Isolated From Human Feces Exhibits Anti-colorectal Cancer Activity.从人粪便中分离出的无细胞上清液具有抗结直肠癌活性。
Front Microbiol. 2021 Nov 11;12:736343. doi: 10.3389/fmicb.2021.736343. eCollection 2021.
2
Identification of microbial markers across populations in early detection of colorectal cancer.跨人群识别微生物标志物用于结直肠癌的早期检测。
Nat Commun. 2021 May 24;12(1):3063. doi: 10.1038/s41467-021-23265-y.
3
-a new functional genus with potential probiotic properties?是否存在具有潜在益生菌特性的新功能属?
肿瘤切除对右半结肠癌患者肠道微生物群失调的影响。
Ann Coloproctol. 2025 Feb;41(1):47-56. doi: 10.3393/ac.2024.00346.0049. Epub 2025 Feb 26.
4
Global prevalence of Fusobacterium nucleatum and Bacteroides fragilis in patients with colorectal cancer: an overview of case reports/case series and meta-analysis of prevalence studies.结直肠癌患者中具核梭杆菌和脆弱拟杆菌的全球患病率:病例报告/病例系列概述及患病率研究的荟萃分析
BMC Gastroenterol. 2025 Feb 10;25(1):71. doi: 10.1186/s12876-025-03664-x.
5
Beneficial microbiome and diet interplay in early-onset colorectal cancer.有益微生物群与饮食在早发性结直肠癌中的相互作用。
EMBO Mol Med. 2025 Jan;17(1):9-30. doi: 10.1038/s44321-024-00177-0. Epub 2024 Dec 9.
6
Immunogenic peptides putatively from intratumor microbes: Opportunities for colorectal cancer treatment.推测来自肿瘤内微生物的免疫原性肽:结直肠癌治疗的机遇
iScience. 2024 Nov 9;27(12):111338. doi: 10.1016/j.isci.2024.111338. eCollection 2024 Dec 20.
7
Inflammasomes Are Influenced by Epigenetic and Autophagy Mechanisms in Colorectal Cancer Signaling.炎性小体受结直肠癌信号转导中表观遗传和自噬机制的影响。
Int J Mol Sci. 2024 Jun 3;25(11):6167. doi: 10.3390/ijms25116167.
8
Role of Gut Microbiome in Neoadjuvant Chemotherapy Response in Urothelial Carcinoma: A Multi-institutional Prospective Cohort Evaluation.肠道微生物组在尿路上皮癌新辅助化疗反应中的作用:多机构前瞻性队列评估。
Cancer Res Commun. 2024 Jun 17;4(6):1505-1516. doi: 10.1158/2767-9764.CRC-23-0479.
9
The colibactin-producing alters the tumor microenvironment to immunosuppressive lipid overload facilitating colorectal cancer progression and chemoresistance.产 colibactin 的 改变肿瘤微环境,使其免疫抑制脂质过载,促进结直肠癌的进展和化疗耐药性。
Gut Microbes. 2024 Jan-Dec;16(1):2320291. doi: 10.1080/19490976.2024.2320291. Epub 2024 Feb 28.
10
Gut microbiota profiles in feces and paired tumor and non-tumor tissues from Colorectal Cancer patients. Relationship to the Body Mass Index.结直肠癌患者粪便以及配对的肿瘤组织和非肿瘤组织中的肠道微生物群谱。与体重指数的关系。
PLoS One. 2023 Oct 5;18(10):e0292551. doi: 10.1371/journal.pone.0292551. eCollection 2023.
Gut Microbes. 2021 Jan-Dec;13(1):1-21. doi: 10.1080/19490976.2021.1875796.
4
Colon Carcinogenesis: The Interplay Between Diet and Gut Microbiota.结肠发生癌变:饮食与肠道微生物群的相互作用。
Front Cell Infect Microbiol. 2020 Dec 8;10:603086. doi: 10.3389/fcimb.2020.603086. eCollection 2020.
5
Hydrogen sulfide toxicity in the gut environment: Meta-analysis of sulfate-reducing and lactic acid bacteria in inflammatory processes.肠道环境中的硫化氢毒性:炎症过程中硫酸盐还原菌和乳酸菌的荟萃分析。
J Adv Res. 2020 Mar 17;27:55-69. doi: 10.1016/j.jare.2020.03.003. eCollection 2021 Jan.
6
Novel Strain and Its Outer Membrane Vesicles Exert Immunoregulatory Effects .新型菌株及其外膜囊泡发挥免疫调节作用。
Front Microbiol. 2020 Nov 12;11:575455. doi: 10.3389/fmicb.2020.575455. eCollection 2020.
7
Comparing DADA2 and OTU clustering approaches in studying the bacterial communities of atopic dermatitis.比较 DADA2 和 OTU 聚类方法在研究特应性皮炎细菌群落中的应用。
J Med Microbiol. 2020 Nov;69(11):1293-1302. doi: 10.1099/jmm.0.001256. Epub 2020 Sep 23.
8
Gut Microbiota-Mediated Inflammation and Gut Permeability in Patients with Obesity and Colorectal Cancer.肠道微生物群介导的肥胖和结直肠癌患者的炎症和肠道通透性。
Int J Mol Sci. 2020 Sep 16;21(18):6782. doi: 10.3390/ijms21186782.
9
Bidirectional interaction between intestinal microbiome and cancer: opportunities for therapeutic interventions.肠道微生物群与癌症之间的双向相互作用:治疗干预的机会
Biomark Res. 2020 Aug 12;8:31. doi: 10.1186/s40364-020-00211-6. eCollection 2020.
10
Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy.微生物组衍生的肌苷调节对检查点抑制剂免疫治疗的反应。
Science. 2020 Sep 18;369(6510):1481-1489. doi: 10.1126/science.abc3421. Epub 2020 Aug 13.